于然, 肖瑶, 王万鹏, 李庆菊, 陈皓瑜, 宋坚, 陈佳佳. 小檗碱通过调节蛋白激酶B缓解对比剂肾病的作用及机制研究[J]. 临床肾脏病杂志, 2024, 24(10): 847-854. DOI: 10.3969/j.issn.1671-2390.2024.10.008
    引用本文: 于然, 肖瑶, 王万鹏, 李庆菊, 陈皓瑜, 宋坚, 陈佳佳. 小檗碱通过调节蛋白激酶B缓解对比剂肾病的作用及机制研究[J]. 临床肾脏病杂志, 2024, 24(10): 847-854. DOI: 10.3969/j.issn.1671-2390.2024.10.008
    Yu Ran, Xiao Yao, Wang Wan-peng, Li Qing-ju, Chen Hao-yu, Song Jian, Chen Jia-jia. Effect and mechanism of berberine in alleviating contrast-induced nephropathy through regulating protein kinase B[J]. Journal of Clinical Nephrology, 2024, 24(10): 847-854. DOI: 10.3969/j.issn.1671-2390.2024.10.008
    Citation: Yu Ran, Xiao Yao, Wang Wan-peng, Li Qing-ju, Chen Hao-yu, Song Jian, Chen Jia-jia. Effect and mechanism of berberine in alleviating contrast-induced nephropathy through regulating protein kinase B[J]. Journal of Clinical Nephrology, 2024, 24(10): 847-854. DOI: 10.3969/j.issn.1671-2390.2024.10.008

    小檗碱通过调节蛋白激酶B缓解对比剂肾病的作用及机制研究

    Effect and mechanism of berberine in alleviating contrast-induced nephropathy through regulating protein kinase B

    • 摘要:
      目的  探究小檗碱(berberine,BBR)对对比剂肾病(contrast-induced nephropathy,CIN)的作用及潜在机制。
      方法  SD大鼠用于构建大鼠CIN模型,BBR治疗组(model+BBR,M+B)大鼠给予200 mg/kg BBR灌胃治疗,对照组(control,Con)大鼠和模型组(model,Mod)大鼠给予等量生理盐水灌胃。人肾皮质近曲小管上皮细胞(human kidney cortex proximal tubule epithelial cells,HK-2)用于构建CIN体外模型,Con组细胞不进行特殊处理,Mod组细胞使用50 g/L碘佛醇作用24 h,M+B组细胞使用50 g/L碘佛醇和30 μmol/L BBR处理24 h。蛋白激酶B(protein kinase B,Akt)激动剂(SC79)和Akt抑制剂(MK2206)用于检测BBR对蛋白激酶B-叉头盒O3-核因子E2相关因子2(protein kinase B-forkhead box O3-nuclear factor erythroid 2-related factor 2,Akt-Foxo3a-Nrf2)调控轴的调节作用。血肌酐(serum creatinine,Scr)检测和HE染色用于评估大鼠肾脏损伤情况。膜联蛋白V-碘化丙啶(annexin V-propidium iodide,Annexin V-PI)染色用于检测各组HK-2细胞凋亡情况。蛋白质印迹法用于检测Akt-Foxo3a-Nrf2调控轴蛋白的表达水平。
      结果  Scr检测结果显示,Mod组大鼠的Scr水平(58.83 ± 7.96)μmol/L比(23.52 ± 0.78)μmol/L高于Con组,M+B组Scr水平(39.64 ± 2.52)μmol/L比(58.83 ± 7.96)μmol/L低于Mod组(P均<0.05)。HE染色结果显示,Con组大鼠肾脏形态正常,肾小管上皮细胞完好,Mod组大鼠肾脏中肾小管结构受损,大量肾小管上皮细胞死亡,肾小管上皮细胞空泡样变明显,M+B组大鼠肾脏中部分肾小管形态恢复,肾小管上皮细胞空泡样变减少,细胞死亡减少。蛋白质印迹法表明,与Con组相比,在Mod组大鼠和HK-2细胞中磷酸化蛋白激酶B(Phospho-protein kinase B,p-Akt)表达增加,差异均具有统计学意义(P均<0.05);M+B组p-Akt表达较Mod组下降(P<0.05);Annexin V-PI凋亡检测显示,与Con组相比,Mod组中HK-2细胞凋亡(12.65 ± 1.25)%比(27.44 ± 0.73)%增加,与Mod组相比,M+B组中HK-2细胞凋亡(27.44 ± 0.73)%比(24.81 ± 0.49)%下降(P均<0.05)。与M+B组相比,BBR与Akt激动剂联合治疗组HK-2细胞凋亡(24.81 ± 0.49)%比(27.50 ± 0.35)%增加(P<0.05)。与Mod组相比,Akt抑制剂治疗组HK-2细胞凋亡(27.65 ± 0.56)%比(25.20 ± 0.64)%减少(P<0.05)。与M+B组相比,MK2206与BBR联合使用能够进一步减少碘佛醇诱导的HK-2细胞凋亡(24.51 ± 0.52)%比(21.24 ± 0.99)%,P<0.05。
      结论  BBR通过调控Akt-Foxo3a-Nrf2轴,在体内和体外发挥抑制CIN的作用,该作用机制是p-Akt依赖性的。

       

      Abstract:
      Objective  To explore the inhibitory effect of berberine (BBR) on contrast-induced nephropathy (CIN) and clarify the underlying mechanism.
      Methods  Sprague-Dawley (SD) rats were utilized for constructing a rat CIN model. BBR treatment group (M+B) received a gavage of 200 mg/kg BBR while control group (Con) and model group (Mod) had an oral intake of the same volume of normal saline. Human kidney cortex proximal tubule epithelial cells (HK-2) were utilized for constructing a CIN cell model in vitro. No special treatment was offered to HK-2 cells in Con group. HK-2 cells in Mod group were treated with 50 g/L ioversol for 24 h and HK-2 cells in M+B group 50 g/L ioversol and 30 μmol/L BBR for 24 h. Akt agonist (SC79) and Akt inhibitor (MK2206) were utilized for confirming the effect of BBR on protein kinase B-forkhead box O3-nuclear factor erythroid 2-related factor 2 (Akt-Foxo3a-Nrf2) regulatory axis. Serum creatinine (Scr) detection and hematoxylin-eosin (HE) stain were employed for evaluating renal injury in rats. Annexin V-propidium iodide (annexin V-PI) stain was used for detecting cell apoptosis. And Western blot was utilized for detecting the protein expression of Akt-Foxo3a-Nrf2 axis.
      Results  The level of Scr was higher in Mod group than that in Con group (58.83 ± 7.96)μmol/L vs (23.52 ± 0.78)μmol/L, P<0.05. And it was lower in M+B group than that in Mod group (39.64 ± 2.52)μmol/L vs (58.83 ± 7.96)μmol/L, P<0.05. HE stain indicated that kidney morphology was normal and renal tubular epithelial cells remained intact in Con group. In Mod group, structure of renal tubules was disarrayed with diffuse death of epithelial cells and obvious vacuolar degeneration of renal tubular epithelial cells. In M+B group, morphology of renal tubules was partially restored and vacuolar degeneration of renal tubule epithelial cells and cell death lessened. Western blot results indicated that, as compared with Con group, the expression of phospho-protein kinase B (p-Akt) was up-regulated in CIN rats and ioversol treated HK-2 cells. And the difference was statistically significant (P<0.05). In M+B group, the expression of p-Akt dropped as compared with Mod group (P<0.05). Annexin V-PI apoptosis assay indicated that, as compared with Con group, cell apoptosis spiked in Mod group (12.65 ± 1.25)% vs (27.44 ± 0.73)%, P<0.05. As compared with Mod group, cell apoptosis declined in M+B group (27.44 ± 0.73)% vs (24.81 ± 0.49)%, P<0.05. As compared with M+B group, cell apoptosis rose in BBR plus SC79 treatment group (24.81 ± 0.49)% vs (27.50 ± 0.35)%, P<0.05. As compared with Mod group, cell apoptosis declined in MK2206 treatment group (27.65 ± 0.56)% vs (25.20 ± 0.64)%, P<0.05. As compared with M+B group, MK2206 plus BBR further reduced ioversol-induced HK-2 cell apoptosis (24.51 ± 0.52)% vs (21.24 ± 0.99)%, P<0.05.
      Conclusion  BBR may suppress CIN in vivo and in vitro through regulating Akt-Foxo3a-Nrf2 axis in a p-Akt dependent mode.

       

    /

    返回文章
    返回